Anzeige
Mehr »
Sonntag, 18.01.2026 - Börsentäglich über 12.000 News
Silber bei 90. Gold bei 4.600. Kupfer bei 6. - Top-Aktie im Fokus
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 882361 | ISIN: US5898891040 | Ticker-Symbol: MM3
Frankfurt
16.01.26 | 21:38
70,00 Euro
+2,19 % +1,50
1-Jahres-Chart
MERIT MEDICAL SYSTEMS INC Chart 1 Jahr
5-Tage-Chart
MERIT MEDICAL SYSTEMS INC 5-Tage-Chart
RealtimeGeldBriefZeit
69,5071,0019:05
70,0072,0016.01.

Aktuelle News zur MERIT MEDICAL SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.01.Merit Medical names F. Ann Millner Board of chair and reports preliminary Q4 2025 revenue1
08.01.Merit Medical Systems reports Preliminary Q4 results1
08.01.Führungswechsel bei Merit Medical: Ann Millner folgt auf Gründer Lampropoulos an der Aufsichtsratsspitze1
08.01.Merit Medical appoints Ann Millner as board chair as founder steps down1
08.01.Merit Medical Systems, Inc.: Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025166SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously...
► Artikel lesen
MERIT MEDICAL SYSTEMS Aktie jetzt für 0€ handeln
08.01.MERIT MEDICAL SYSTEMS INC - 8-K, Current Report-
23.12.25Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now1
27.11.25Executive Chairman Of Merit Medical Systems Sold $880K In Stock1
25.11.25Insider Unloading: Fred Lampropoulos Sells $2.18M Worth Of Merit Medical Systems Shares1
21.11.25Merit Medical Systems Executive Chairman Sold $424K In Company Stock1
14.11.25Merit Medical to launch Wrapsody endoprosthesis in U.S. after CMS defers reimbursement decision4
14.11.25Verzögerung bei Wrapsody: Canaccord senkt Kursziel für Merit Medical auf 93 US-Dollar2
14.11.25Merit Medical stock price target lowered to $93 at Canaccord on Wrapsody reimbursement delay1
13.11.25Merit Medical withdraws application for Medicare payment boost2
13.11.25MERIT MEDICAL SYSTEMS INC - 8-K, Current Report-
05.11.25Merit Medical Systems, Inc.: Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial175The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty...
► Artikel lesen
03.11.25Merit Medical Systems, Inc.: Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial172At 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical...
► Artikel lesen
31.10.25Merit Medical Q3 Earnings & Revenues Beat Estimate, Margins Expand1
31.10.25Where Merit Medical Systems Stands With Analysts3
31.10.25Merit Medical targets $175M free cash flow in 2025 with updated guidance and new CEO at helm1
Weiter >>
59 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1